-
Mashup Score: 0FDA approves Tecvayli for advanced multiple myeloma - 1 year(s) ago
December 06, 2022 2 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an…
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Bispecific antibody achieved durable responses in a majority of heavily pretreated patients
Source: www.medpagetoday.comCategories: Latest Headlines, Oncologists2Tweet-
#FDAApproved ✅ Treatment options for relapsed/refractory #multiplemyeloma continue to expand with FDA's #acceleratedapproval of #teclistamab (#Tecvayli). "These are remarkable results," said principal investigator @szusmani of @MSKCancerCenter. https://t.co/Rso0M3wBLA
-
-
Mashup Score: 0FDA approves Tecvayli for advanced multiple myeloma - 2 year(s) ago
The FDA granted accelerated approval to teclistamab-cqyv for treatment of certain patients of myeloma. The indication applies to use of teclistamab-cqyv (Tecvayli, Janssen Biotech) for adults with relapsed or refractory multiple myeloma who received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
FDA APPROVED: Tecvayli for advanced multiple myeloma. https://t.co/NzJmV44AzD #Tecvayli #myeloma #HemOnc #OncAlert #MedEd @JanssenUS @US_FDA
-
FDA APPROVED: Tecvayli for advanced multiple myeloma. https://t.co/E4XOG2oVwh #myeloma #Tecvayli @JanssenUS @IcahnMountSinai #HemOnc #OncAlert #MedEd @US_FDA